» Articles » PMID: 8569363

Comparison of Leg Compression Stocking and Oral Horse-chestnut Seed Extract Therapy in Patients with Chronic Venous Insufficiency

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1996 Feb 3
PMID 8569363
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diseases of the venous system are widespread disorders sometimes associated with modern civilisation and are among the major concerns of social and occupational medicine. This study was carried out to compare the efficacy (oedema reduction) and safety of compression stockings class II and dried horse chestnut seed extract (HCSE, 50 mg aescin, twice daily).

Methods: Equivalence of both therapies was examined in a novel hierarchical statistical design in 240 patients with chronic venous insufficiency. Patients were treated over a period of 12 weeks in a randomised, partially blinded, placebo-controlled, parallel study design.

Findings: Lower leg volume of the more severely affected limb decreased on average by 43.8 mL (n = 95) with HCSE and 46.7 mL (n = 99) with compression therapy, while it increased by 9.8 mL with placebo (n = 46) after 12 weeks therapy for the intention-to-treat group (95% CI: HCSE: 21.1-66.4; compression: 30.4-63.0; placebo: 40.0-20.4). Significant oedema reductions were achieved by HCSE (p = 0.005) and compression (p = 0.002) compared to placebo, and the two therapies were shown to be equivalent (p = 0.001); in this design, however, compression could not be proven as standard with regard to oedema reduction in the statistical test procedure. Both HCSE and compression therapy were well tolerated and no serious treatment-related events were reported.

Interpretation: These results indicate that compression stocking therapy and HCSE therapy are alternative therapies for the effective treatment of patients with oedema resulting from chronic venous insufficiency.

Citing Articles

Characterization of the horse chestnut genome reveals the evolution of aescin and aesculin biosynthesis.

Sun W, Yin Q, Wan H, Gao R, Xiong C, Xie C Nat Commun. 2023; 14(1):6470.

PMID: 37833361 PMC: 10576086. DOI: 10.1038/s41467-023-42253-y.


The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional....

Gloviczki P, Lawrence P, Wasan S, Meissner M, Almeida J, Brown K J Vasc Surg Venous Lymphat Disord. 2023; 12(1):101670.

PMID: 37652254 PMC: 11523430. DOI: 10.1016/j.jvsv.2023.08.011.


Escin's Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review.

Fazliev S, Tursunov K, Razzokov J, Sharipov A Biomolecules. 2023; 13(2).

PMID: 36830684 PMC: 9952945. DOI: 10.3390/biom13020315.


S2k guidelines: diagnosis and treatment of varicose veins.

Pannier F, Noppeney T, Alm J, Breu F, Bruning G, Flessenkamper I Hautarzt. 2022; 73(Suppl 1):1-44.

PMID: 35438355 PMC: 9358954. DOI: 10.1007/s00105-022-04977-8.


Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration.

Knight Nee Shingler S, Robertson L, Stewart M Cochrane Database Syst Rev. 2021; 7:CD008819.

PMID: 34271595 PMC: 8407251. DOI: 10.1002/14651858.CD008819.pub4.